Article
High Expression of CKS2 Predicts Adverse Outcomes: A Potential Therapeutic Target for Glioma
19 May 2022
Abstract excerpt
Cyclin-dependent kinase regulatory subunit 2 (CKS2) is a potential prognostic marker and is overexpressed in various cancers. This study analyzed sequencing and clinical data from The Cancer Genome Atlas (TCGA) and Gene Expression Omnibus, with external validation using the Chinese Glioma Genome Atlas (CGGA) data. CKS2 expression in the normal brain and tumor tissue was compared. cBioPortal and MethSurv were...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
